Also, a recent study reported the role of entinostat in inducing changes in multiple myeloid cell types, reducing immunosuppression, increasing antitumor immune responses, and improving sensitivity to immunotherapy for HER2+ breast cancer [82], which indicated the combinatorial effects of entinostat with immunotherapy for middle immune score samples. Here, ERBB2 is linked to breast cancer.